2026-02-19 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces its financial results for the year ended December 31, 2025. FY 2025 key results1 Group performance2: Double-digit revenue growth and positive…
